Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach.
暂无分享，去创建一个
A. Drilon | J. Berlin | B. Geoerger | D. Tan | D. Hong | S. Bielack | S. Kummar | C. M. Tilburg | R. Schilder | R. McDermott | D. Oh | F. Doz | U. Lassen | S Kummar | L. Mascarenhas | S. DuBois | F Doz | N Federman | C M van Tilburg | S S Bielack | N. Federman | R J Schilder | U N Lassen | C M Albert | S G Dubois | B Geoerger | L Mascarenhas | J D Berlin | D-Y Oh | R McDermott | D S Tan | S Cruickshank | N C Ku | M C Cox | A Drilon | D S Hong | C. V. van Tilburg | S. Cruickshank | C. Albert | M. Cox | N. Ku | Leo Mascarenhas | S. Bielack | U. Lassen | David S. Hong | F. Doz | Steven G. DuBois | Birgit Geoerger | Michael C. Cox | Scott Cruickshank | C. M. Albert | Russell J. Schilder | J. Berlin | R. S. McDermott | D.S.W. Tan | Nora Ku